Last reviewed · How we verify
Cosiporfin Sodium for injection, DVDMS
Cosiporfin Sodium for injection, DVDMS is a Small molecule drug developed by Shanghai Guangsheng Biopharmaceutical Co., Ltd. It is currently in Phase 2 development.
At a glance
| Generic name | Cosiporfin Sodium for injection, DVDMS |
|---|---|
| Sponsor | Shanghai Guangsheng Biopharmaceutical Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cosiporfin Sodium for injection, DVDMS CI brief — competitive landscape report
- Cosiporfin Sodium for injection, DVDMS updates RSS · CI watch RSS
- Shanghai Guangsheng Biopharmaceutical Co., Ltd portfolio CI
Frequently asked questions about Cosiporfin Sodium for injection, DVDMS
What is Cosiporfin Sodium for injection, DVDMS?
Cosiporfin Sodium for injection, DVDMS is a Small molecule drug developed by Shanghai Guangsheng Biopharmaceutical Co., Ltd.
Who makes Cosiporfin Sodium for injection, DVDMS?
Cosiporfin Sodium for injection, DVDMS is developed by Shanghai Guangsheng Biopharmaceutical Co., Ltd (see full Shanghai Guangsheng Biopharmaceutical Co., Ltd pipeline at /company/shanghai-guangsheng-biopharmaceutical-co-ltd).
What development phase is Cosiporfin Sodium for injection, DVDMS in?
Cosiporfin Sodium for injection, DVDMS is in Phase 2.